The Executive Director, GxP Center of Excellence (CoE) reports into VP, R&D Quality. It is a strategic leadership role responsible for establishing and leading an enterprise-wide GxP (GCP, GLP and GVP) quality capability that drives consistent, data driven, risk-ballanced practices and inspection readiness across R&D and associated functions. This role integrates vendor quality, device quality, GxP inspections, CAPA and Investigation Excellence, business development (M&A), governance, QMS, project management, training and knowledge management into a unified CoE operating model.The leader will ensure quality by design, proactive risk management, and regulatory compliance while enabling innovation, speed, and scalable growth across the portfolio. Through active participation in relevant governance forums, this role oversees the identification, escalation, and mitigation of quality and compliance risks while driving continuous improvement, operational effectiveness, inspection readiness, and quality culture.
The leader champions enterprise-wide quality transformation, leveraging data-driven insights, digital innovation, and cross-functional collaboration to strengthen compliance, enhance organizational capabilities, and enable the efficient delivery of medicines to patients.The leader establishes and evolves the strategic vision, roadmap, and operating model for key quality capabilities with the CoE. Through continuous improvement, digital innovation, and operational excellence, this role builds future-ready capabilities that strengthen compliance, enhance organizational effectiveness, and accelerate the delivery of innovative therapies to patients.